Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
10m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
10m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
10m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
10m agoFirst Quantum Minerals Reports First Quarter 2026 Results
11m agoDistrict Metals Announces $10 Million Private Placement Financing
X4 Pharmaceuticals Inc logo

X4 Pharmaceuticals Inc

About

X4 Pharmaceuticals Inc (NASDAQ:XFOR) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 17 2026
X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar 4 2026
X4 Pharmaceuticals to Participate in a Fireside Chat at the Leerink Global Healthcare Conference
Mar 2 2026
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 27 2026
X4 Pharmaceuticals Receives Positive Opinion from the EMA CHMP Recommending Approval of Mavorixafor in the EU for WHIM Syndrome
Feb 3 2026
X4 Pharmaceuticals to Participate in Guggenheim’s Emerging Outlook: Biotech Summit 2026

Financials

Revenue
$35.11 M
Market Cap
$370.04 M
EPS
-1.87

Community Chat

Ask AI

6ix6ixAIEvents